FHL2

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA005922

Antibody HPA006028

Antibody CAB008368

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Malignant tissues generally displayed weak to moderate cytoplasmic staining. Strongest positivity was found in urothelial cancers.Most malignant cells were negative. Strong cytoplasmic immunoreactivity, in some cases accompanied with nuclear staining, was observed in a few cases of endometrial, ovarian and urothelial carcinomas.Most tumors were weakly stained or negative. Moderately positivity was observed in several cases of urothelial, skin and ovarian cancers.

Literature conformity

Partly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization dataConsistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected